IL17A and psoriatic arthritis: Impairment of BTI is an important pathologic feature of psoriatic arthritis, and pathological activation of the IL-23/IL-17 axis triggers an inflammatory response in BTI, and counter-regulation between the Th17 and Th2 pathways in the BTI region is involved in the development of psoriatic arthritis (15, 16).